Immune Pharmaceuticals Ltd.

Immune Pharmaceuticals Ltd. Immune Pharmaceuticals Inc. applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve patients lives

IMMUNE is an emerging leader in the development of Monoclonal Antibodies for the treatment of Inflammatory Diseases and Cancer. Monoclonal Antibodies are one of the most attractive pharmaceutical markets with annual sales of over $50 billion, continued double digit growth, 5 out of the top 10 pharmaceuticals, high market valuation and rich partnerships, including for earlier development stage drugs.

Address

Herzliya

Website

Alerts

Be the first to know and let us send you an email when Immune Pharmaceuticals Ltd. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram